Name: CLSI I/LA25 A2 : 2011
Brand: CLSI
Price: 273.60 USD

MATERNAL SERUM SCREENING

Available format(s)

Hardcopy , PDF

Language(s)

English

Published date

04-28-2011

Publisher

Clinical Laboratory Standards Institute

Abstract
Committee Membership
Foreword
1 Scope
2 Introduction
3 Standard Precautions
4 Terminology
5 Specimen Collection
6 Screening Markers
7 Maternal Serum Screening for Open Netural Tube Defects
8 Screening for Trisomy 21
9 Relationship of False-Positive Screen Test to Adverse
Outcome
10 Quality Control
11 Management of Women With Screen-Positive Results
12 Incidental Detection of Edwards Syndrome (Trisomy 18)
13 Program Evaluation
References
Appendix - Amniotic Fluid Alpha-fetoprotein for Detection of
Open Neural Tube Defects
The Quality Management System Approach
Related CLSI Reference Materials

This standard specifies requirements and recommendations for maternal serum aspects of prenatal screening for neural tube defects (NTDs) and trisomy 21 (T21) (Down syndrome [DS]) and incorporates ultrasound measurements to ensure that screening methods and quality control procedures are carried out to a high standard.

DevelopmentNote	Supersedes NCCLS I/LA25 A. (05/2011)
DocumentType	Standard
ISBN	1-56238-749-9
Pages	64
PublisherName	Clinical Laboratory Standards Institute
Status	Current
Supersedes	CLSI I/LA25 A : 1ED 2004

CLSI M29 A3 : 3ED 2005	ACQUIRED INFECTIONS; APPROVED GUIDELINE
CLSI C24 A3 : 3ED 2006	STATISTICAL QUALITY CONTROL FOR QUANTITATIVE MEASUREMENT PROCEDURES: PRINCIPLES AND DEFINITIONS
CLSI EP9 A2 : 2ED 2002	METHOD COMPARISON AND BIAS ESTIMATION USING PATIENT SAMPLES